Every Cat Logo


W09-017: Feline hypertrophic cardiomyopathy: five year outcomes and risk assessment

Hypertrophic cardiomyopathy (HCM) is the most important cause of cardiovascular morbidity and mortality in the cat. Nevertheless, its natural history is unresolved, and factors that promote heart failure and cardiac death remain unidentified. Risk factor identification in human HCM patients has greatly improved patient health and survival. Of particular relevance are positive family history of cardiac morbidity, genetic mutations, presence of cardiac outflow tract obstruction and arrhythmias, and magnitude of ventricular thickening. This study is the first comprehensive clinical analysis of feline HCM by virtue of evaluating a large population of 1,200 cats to assess risk factors for heart failure and death. The investigators will identify cats that were diagnosed five years ago with asymptomatic and symptomatic forms of HCM, as well as healthy cats that were examined over the same period for comparison. They will prospectively analyze their echocardiograms, review their history and medical record data, and then conduct follow up health surveys with their owners. Results of this study should contribute meaningfully to developing more useful and cost effective disease monitoring, improving treatment strategies, enhancing ability to assess cardiac risk, and improving accuracy for prognosis.
(Ricky Fund Study)

Grant ID: W09-017

Status: Active

Year Funded: 2009

Amount awarded: $14,050

Investigator: Philip Fox, DVM, MS, DACVIM, DECVIM, DACVECC; The Animal Medical Center